International Recognition Procedure From January 2024, the MHRA is adopting the International Recognition Procedure, reflecting a strategic pivot towards an independent and collaborative regulatory framework for swift and secure drug authorizations in the UK. Our [...]
Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (VPAG) The new VPAG scheme is due to come in effect in January 2024 lasting for 5 years. The scheme, which has been agreed between the [...]
WEP News All News20232021202220202019201820172016WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY)1st December 2023/Read More2023WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED [...]
Managing patient requests for Your investigational medicines Expanded Access Programs (EAPs) allow companies to provide their investigational medicines to patients outside of the clinical trial setting, to fulfil unmet clinical needs.WEP has put together a [...]
Thank you for your interest in WEP Please see the resource below and check your inbox for the PDF version Managing patient requests for Your investigational medicines Are you receiving unsolicited requests for your phase [...]
Complete the form below and we will reach out to confirm your booking US +1 919-694-5088INFO@WEPCLINICAL.COM 951 AVIATION PARKWAY, SUITE 200, MORRISVILLE, NC, 27560 UK +44 208 004 8185INFO@WEPCLINICAL.COM CHISWICK TOWER, 389 CHISWICK HIGH ROAD, 14TH [...]
Navigating the Future of EU Joint Health Technology Assessments With the Health Technology Assessment (HTA) landscape undergoing transformation in January 2025, it's essential to prepare your pipeline for what lies ahead. Our Market Access team [...]
Early Access Programs allow patients and physicians to use investigational (pre-approval) drugs outside the clinical trial setting. They are often referred to as Expanded Access Programs (EAPs), Compassionate Use Programs (CUPs), or Managed Access [...]
With Every Patient At WEP, we are With Every Patient With this as our guiding principle, we operate as a Pharmaceutical Services Provider committed to delivering Drug Development, Treatment Access, and Commercialization Solutions for Sponsors [...]
Home Health Solutions In 2021, WEP Clinical acquired Wren Healthcare, a clinical nursing solutions company.With the addition of Wren Healthcare, we now offer first-in-class Home Nursing Services for Clinical Trials and Access Programs globally.To learn more about our nursing [...]
